Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 11/2008

01-11-2008 | Original Paper

Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2

Authors: Susanne Steinert, Torsten C. Kroll, Isabel Taubert, Larissa Pusch, Peter Hortschansky, Klaus Höffken, Stefan Wölfl, Joachim H. Clement

Published in: Journal of Cancer Research and Clinical Oncology | Issue 11/2008

Login to get access

Abstract

Purpose

Bone morphogenetic proteins (BMPs) are multifunctional regulators of various cell functions. The BMP-signalling network plays a pivotal role during embryogenesis and tumorigenesis. BMPs, e.g. BMP-2 exert their biological function in a time and concentration-dependent manner but also modulated by the context of the cellular microenvironment. In this study, we investigated the effect of a steady high level of BMP-2 versus a single application of BMP-2 on the breast cancer cell line MCF-7.

Methods

The effect of the incubation regimes was analysed by DNA microarray expression profiling. Data were verified by real-time PCR. The protein expression of apoptosis-related genes was studied by western blot analysis.

Results

We found a clear difference in the altered gene expression between the constant high level and the single application of BMP-2. After grouping the genes of interest into the biological processes of Gene Ontology, the group of apoptosis-related genes like BAX, BAG5 or PKR, was predominantly affected under the single-application regime of BMP-2. Among these protein kinase R was the most prominently regulated. Further studies on the protein level showed activation of PKR after 4 h with a subsequent enhanced phosphorylation of the PKR substrate eIF2alpha for several hours.

Conclusions

The duration of treatment and the concentration of BMP-2 affect the global expression pattern of MCF-7 cells. Among the regulated cancer-related genes, the cohort of the apoptosis-related genes showed the pronounced alterations. Our data point to a novel role of BMP-2 in the regulation of the PKR pathway in tumorigenesis.
Literature
go back to reference Adachi T, Takanaga H, Kunimoto M, Asou H (2005) Influence of LIF and BMP-2 on differentiation and development of glial cells in primary cultures of embryonic rat cerebral hemisphere. J Neurosci Res 79:608–615PubMedCrossRef Adachi T, Takanaga H, Kunimoto M, Asou H (2005) Influence of LIF and BMP-2 on differentiation and development of glial cells in primary cultures of embryonic rat cerebral hemisphere. J Neurosci Res 79:608–615PubMedCrossRef
go back to reference Alarmo EL, Kuukasjärvi T, Karhu R, Kallioniemi A (2007) A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 103:239–246PubMedCrossRef Alarmo EL, Kuukasjärvi T, Karhu R, Kallioniemi A (2007) A comprehensive expression survey of bone morphogenetic proteins in breast cancer highlights the importance of BMP4 and BMP7. Breast Cancer Res Treat 103:239–246PubMedCrossRef
go back to reference Al-Sharour F, Dìaz-Uriarte R, Dopazo J (2004) FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20:578–580CrossRef Al-Sharour F, Dìaz-Uriarte R, Dopazo J (2004) FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 20:578–580CrossRef
go back to reference Bobinac D, Maric I, Zoricic S, Spanjol J, Dordevic G, Mustac E, Fuckar Z (2005) Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 46:389–396PubMed Bobinac D, Maric I, Zoricic S, Spanjol J, Dordevic G, Mustac E, Fuckar Z (2005) Expression of bone morphogenetic proteins in human metastatic prostate and breast cancer. Croat Med J 46:389–396PubMed
go back to reference Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254PubMedCrossRef Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254PubMedCrossRef
go back to reference Clement JH, Wölfl S (2004) Bone morphogenetic proteins and cancer. In: Vukicevic S, Sampath KT (eds) Bone morphogenetic proteins: regeneration of bone and beyond. Birkhäuser, Basel, pp 267–292 Clement JH, Wölfl S (2004) Bone morphogenetic proteins and cancer. In: Vukicevic S, Sampath KT (eds) Bone morphogenetic proteins: regeneration of bone and beyond. Birkhäuser, Basel, pp 267–292
go back to reference Clement JH, Fettes P, Knöchel S, Lef J, Knöchel W (1995) Bone morphogenetic protein 2 in early development of Xenopus laevis. Mech Dev 52:357–370PubMedCrossRef Clement JH, Fettes P, Knöchel S, Lef J, Knöchel W (1995) Bone morphogenetic protein 2 in early development of Xenopus laevis. Mech Dev 52:357–370PubMedCrossRef
go back to reference Clement JH, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Höffken K, Wölfl S (2000) BMP-2 induces sequential changes of ID gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 126:271–279PubMedCrossRef Clement JH, Marr N, Meissner A, Schwalbe M, Sebald W, Kliche KO, Höffken K, Wölfl S (2000) BMP-2 induces sequential changes of ID gene expression in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol 126:271–279PubMedCrossRef
go back to reference Clement JH, Raida M, Sänger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A, Höffken K, Wölfl S, Harris AL (2005) Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 27:401–407PubMed Clement JH, Raida M, Sänger J, Bicknell R, Liu J, Naumann A, Geyer A, Waldau A, Hortschansky P, Schmidt A, Höffken K, Wölfl S, Harris AL (2005) Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. Int J Oncol 27:401–407PubMed
go back to reference The Gene Ontology Consortium (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25:25–29 The Gene Ontology Consortium (2000) Gene Ontology: tool for the unification of biology. Nat Genet 25:25–29
go back to reference Desprez PY, Hara E, Bissel MJ, Campisi J (1995) Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol 15:3398–3404PubMed Desprez PY, Hara E, Bissel MJ, Campisi J (1995) Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol 15:3398–3404PubMed
go back to reference Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissel MJ, Campisi J (1998) A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 18:4577–4588PubMed Desprez PY, Lin CQ, Thomasset N, Sympson CJ, Bissel MJ, Campisi J (1998) A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 18:4577–4588PubMed
go back to reference Doherty MJ, Young PR, Cohen TW (1996) Amino acid sequence of a novel protein phosphatase 1 binding protein (R5) which is related to the liver- and muscle-specific glycogen binding subunits of protein phosphatase 1. FEBS Lett 399:339–343PubMedCrossRef Doherty MJ, Young PR, Cohen TW (1996) Amino acid sequence of a novel protein phosphatase 1 binding protein (R5) which is related to the liver- and muscle-specific glycogen binding subunits of protein phosphatase 1. FEBS Lett 399:339–343PubMedCrossRef
go back to reference Hayashi A, Seki N, Hattori A, Kozuma S, Saito T (1999) PKCν, a new member of the protein kinase C family, composes a fourth subfamily with PKCμ. Biochim Biophys Acta 1450:99–106PubMedCrossRef Hayashi A, Seki N, Hattori A, Kozuma S, Saito T (1999) PKCν, a new member of the protein kinase C family, composes a fourth subfamily with PKCμ. Biochim Biophys Acta 1450:99–106PubMedCrossRef
go back to reference Hogan BLM (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580–1594PubMedCrossRef Hogan BLM (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 10:1580–1594PubMedCrossRef
go back to reference Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O’Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL (2004) Loss of BMP-2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 59:234–242PubMedCrossRef Horvath LG, Henshall SM, Kench JG, Turner JJ, Golovsky D, Brenner PC, O’Neill GF, Kooner R, Stricker PD, Grygiel JJ, Sutherland RL (2004) Loss of BMP-2, Smad8, and Smad4 expression in prostate cancer progression. Prostate 59:234–242PubMedCrossRef
go back to reference Izumi M, Masaki M, Hiramoto Y, Sugiyama S, Kuroda T, Terai K, Hori M, Kawase I, Hirota H (2006) Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes. J Mol Cell Cardiol 40:224–233PubMedCrossRef Izumi M, Masaki M, Hiramoto Y, Sugiyama S, Kuroda T, Terai K, Hori M, Kawase I, Hirota H (2006) Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes. J Mol Cell Cardiol 40:224–233PubMedCrossRef
go back to reference Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755–1766PubMedCrossRef Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127:1755–1766PubMedCrossRef
go back to reference Kaufmann SH, Gores GJ (2000) Apoptosis in cancer: cause and cure. Bioassays 22:1007–1017CrossRef Kaufmann SH, Gores GJ (2000) Apoptosis in cancer: cause and cure. Bioassays 22:1007–1017CrossRef
go back to reference Langenfeld EM, Bojnowski J, Perone J, Langenfeld J (2005a) Expression of bone morphogenetic proteins in human lung carcinoma. Ann Thorac Surg 80:1028–1032PubMedCrossRef Langenfeld EM, Bojnowski J, Perone J, Langenfeld J (2005a) Expression of bone morphogenetic proteins in human lung carcinoma. Ann Thorac Surg 80:1028–1032PubMedCrossRef
go back to reference Langenfeld EM, Kong Y, Langenfeld J (2005b) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25:685–692CrossRef Langenfeld EM, Kong Y, Langenfeld J (2005b) Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene 25:685–692CrossRef
go back to reference Ogata T, Wozney JM, Benezra R, Noda M (1993) Bone morphogentic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA 90:9219–9222PubMedCrossRef Ogata T, Wozney JM, Benezra R, Noda M (1993) Bone morphogentic protein 2 transiently enhances expression of a gene, Id (inhibitor of differentiation), encoding a helix-loop-helix molecule in osteoblast-like cells. Proc Natl Acad Sci USA 90:9219–9222PubMedCrossRef
go back to reference Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE, Dale TC (1996) Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development 122:2729–2739PubMed Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE, Dale TC (1996) Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development 122:2729–2739PubMed
go back to reference Ponti D, Zaffaroni N, Capelli C, Daidone MG (2006) Breast cancer stem cells: an overview. Eur J Cancer 42:1219–1224PubMedCrossRef Ponti D, Zaffaroni N, Capelli C, Daidone MG (2006) Breast cancer stem cells: an overview. Eur J Cancer 42:1219–1224PubMedCrossRef
go back to reference Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL (2005) Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131:741–750PubMedCrossRef Raida M, Clement JH, Leek RD, Ameri K, Bicknell R, Niederwieser D, Harris AL (2005) Bone morphogenetic protein 2 (BMP-2) and induction of tumor angiogenesis. J Cancer Res Clin Oncol 131:741–750PubMedCrossRef
go back to reference Savinova O, Joshi B, Jagus R (1999) Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. Int J Biochem Cell Biol 31:175–189PubMedCrossRef Savinova O, Joshi B, Jagus R (1999) Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. Int J Biochem Cell Biol 31:175–189PubMedCrossRef
go back to reference Schwalbe M, Sänger J, Eggers R, Naumann A, Schmidt A, Höffken K, Clement JH (2003) Differential expression and regulation of bone morphogentic protein 7 in breast cancer. Int J Oncol 23:89–95PubMed Schwalbe M, Sänger J, Eggers R, Naumann A, Schmidt A, Höffken K, Clement JH (2003) Differential expression and regulation of bone morphogentic protein 7 in breast cancer. Int J Oncol 23:89–95PubMed
go back to reference Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakern R, Mak TW, Lowe SW (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156–159PubMedCrossRef Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakern R, Mak TW, Lowe SW (1999) Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156–159PubMedCrossRef
go back to reference Steinert S, Ludwig M, Naumann A, Geyer A, Clement JH (2005) BMP-2 reguliert das Migrationsverhalten von Mammakarzinomzellen in vitro. BIOspektrum 4(05):470–471 Steinert S, Ludwig M, Naumann A, Geyer A, Clement JH (2005) BMP-2 reguliert das Migrationsverhalten von Mammakarzinomzellen in vitro. BIOspektrum 4(05):470–471
go back to reference Szeto DP, Kimelman D (2004) Combinatorial gene regulation by Bmp and Wnt in zebrafish posterior mesoderm formation. Development 131:3751–3760PubMedCrossRef Szeto DP, Kimelman D (2004) Combinatorial gene regulation by Bmp and Wnt in zebrafish posterior mesoderm formation. Development 131:3751–3760PubMedCrossRef
go back to reference Vaux DL, Cory S, Adams JM (1998) Bcl-2 gene promotes haemopoietic cell survival and cooporates with c-myc to immortalize pre-B cells. Nature 335:440–442CrossRef Vaux DL, Cory S, Adams JM (1998) Bcl-2 gene promotes haemopoietic cell survival and cooporates with c-myc to immortalize pre-B cells. Nature 335:440–442CrossRef
go back to reference Wen XZ, Akiyama Y, Baylin SB, Yuasa Y (2006) Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. Oncogene 25:2666–2673PubMedCrossRef Wen XZ, Akiyama Y, Baylin SB, Yuasa Y (2006) Frequent epigenetic silencing of the bone morphogenetic protein 2 gene through methylation in gastric carcinomas. Oncogene 25:2666–2673PubMedCrossRef
go back to reference Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534PubMedCrossRef Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA (1988) Novel regulators of bone formation: molecular clones and activities. Science 242:1528–1534PubMedCrossRef
Metadata
Title
Differential expression of cancer-related genes by single and permanent exposure to bone morphogenetic protein 2
Authors
Susanne Steinert
Torsten C. Kroll
Isabel Taubert
Larissa Pusch
Peter Hortschansky
Klaus Höffken
Stefan Wölfl
Joachim H. Clement
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 11/2008
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-008-0396-0

Other articles of this Issue 11/2008

Journal of Cancer Research and Clinical Oncology 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.